ketotifen/naphazoline ophthalmic solution

· Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ketotifen/naphazoline ophthalmic solution, covering 2020-10-27 to 2020-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis. [Phase 3]

See pricing